During the past decade, Johanniter Krankenhaus conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johanniter Krankenhaus" #1 sponsor was "University Hospital Schleswig-Holstein" with 2 trials, followed by "Biotronik SE & Co. KG" with 1 trials sponsored, "ETOP IBCSG Partners Foundation" with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored and "German Breast Group" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johanniter Krankenhaus" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Central European Cooperative Oncology Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Johanniter Krankenhaus" are "Breast Cancer" (4 trials), "Acute Myeloid Leukemia (AML)" (1 trials), "BRCA 1 /2 and / or HRD" (1 trials), "Bladder Cancer" (1 trials) and "Breast Cancer After Breast Conserving Surgery Indicating Postoperative Radiotherapy With Boost" (1 trials). Many other conditions were trialed in "Johanniter Krankenhaus" in a lesser frequency.

Most popular intervention types in "Johanniter Krankenhaus" are "Drug" (6 trials), "Procedure" (2 trials), "Radiation" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracil" (1 trials), "Bevacizumab" (1 trials), "CRT-D implantation" (1 trials), "CRT-P implantation" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Johanniter Krankenhaus" are 7 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Johanniter Krankenhaus". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Johanniter Krankenhaus, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Johanniter Krankenhaus, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Johanniter Krankenhaus has several departments that took part in Clinical trials: "Praxis für gynäkologische Onkologie am Ev. Krankenhaus Bethesda" - 2 trials, "Johanniter-Krankenhaus im Fläming Treuenbrietzen GmbH; Fachklinik Pneumologie/ Thoraxchirurgie" - 2 trials